Danish pharmaceutical giant Novo Nordisk has seen remarkable success in China over the past three decades, with its operations in Tianjin expanding from basic packaging to a fully integrated industrial chain. The company's vice president highlights the importance of local sourcing, which allows for faster production. With automated assembly lines running at full capacity, the facility produces approximately 200 insulin pens every minute.